In-Q-Tel B.Next (Bio VC)
artifactIntelligence & Surveillance · The Blackmail Network · Biotech & Transhumanism · Darknet & Cyber
The CIA's venture fund has a biology arm investing in gene-sequencing and synthetic biology.
Who they are
B.Next, a lab set up in 2015 by the CIA's venture-capital arm In-Q-Tel.
What they do
The engine treats it as the documented bridge extending state venture capital into the biology and genomics field.
How it works
Established in 2015 focused on biosecurity, it broadened into engineering biology, genomics, synthetic biology, and biological big data, and made a strategic investment in the gene-sequencing firm Kailos Genetics in July 2017.
Why it matters
It shows shared state sponsorship spanning both information technology and biology, though the engine calls this a parallel, documented connection rather than proof of one fused apparatus.
The engine's record — word for word
[Report #111 — Epstein Eugenics/Statecraft] B.Next, an IQT Lab established 2015 by In-Q-Tel (the CIA's VC arm), focused on biosecurity then broadened across 'engineering biology, genomics, synthetic biology, biological big data.' Made a strategic investment in / partnership with Kailos Genetics (next-gen sequencing) Jul 11 2017. The documented state-VC bridge into the biology layer — shared STATE sponsorship across the information-rail and biology-substrate, NOT a fused corporate apparatus. Disposition: documented-connection (parallel/shared-state, not fusion). [Fact-checked Jun 17 2026.]
Follow the trail
Walk this on the live map →